STERIS (STE) Stock Price, News & Analysis

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" STE shares.
View STE analyst ratings or view top-rated stocks.

6 brokers have issued 1-year price targets for STERIS's stock. Their STE share price targets range from $215.00 to $265.00. On average, they expect the company's stock price to reach $239.60 in the next twelve months. This suggests a possible upside of 20.1% from the stock's current price.
View analysts price targets for STE or view top-rated stocks among Wall Street analysts.

STERIS's stock was trading at $219.85 at the beginning of the year. Since then, STE stock has decreased by 9.3% and is now trading at $199.51.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our STE earnings forecast.

STERIS plc (NYSE:STE) released its earnings results on Wednesday, February, 7th. The medical equipment provider reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.17 by $0.05. The medical equipment provider earned $1.40 billion during the quarter, compared to analyst estimates of $1.35 billion. STERIS had a trailing twelve-month return on equity of 13.67% and a net margin of 10.48%. The firm's revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.02 EPS.
Read the conference call transcript.

STERIS declared a quarterly dividend on Tuesday, January 30th. Investors of record on Friday, February 23rd will be paid a dividend of $0.52 per share on Friday, March 22nd. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date is Thursday, February 22nd.
Read our dividend analysis for STE.

STERIS (NYSE:STE) pays an annual dividend of $2.08 per share and currently has a dividend yield of 1.04%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 36.43%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STE will have a dividend payout ratio of 21.85% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for STE.

ETFs with the largest weight of STERIS (NYSE:STE) stock in their portfolio include VanEck Environmental Services ETF (EVX), iShares U.S. Medical Devices ETF (IHI), Running Oak Efficient Growth ETF (RUNN), Nuveen ESG Mid-Cap Value ETF (NUMV), Invesco S&P 500 Equal Weight Health Care ETF (RYH), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), First Trust Indxx Medical Devices ETF (MDEV) and SPDR S&P Health Care Equipment ETF (XHE).

STERIS updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share guidance of 8.600-8.700 for the period, compared to the consensus estimate of 8.670. The company issued revenue guidance of $5.5 billion-$5.5 billion, compared to the consensus revenue estimate of $5.4 billion.

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

STERIS's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (0.63%), Sumitomo Mitsui Trust Holdings Inc. (0.24%), Artemis Investment Management LLP (0.18%), Congress Wealth Management LLC DE (0.12%), Norden Group LLC (0.10%) and Running Oak Capital LLC (0.05%). Insiders that own company stock include Cary L Majors, Cynthia L Feldmann, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi and Renato Tamaro.
View institutional ownership trends.

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.